# FDA 483 - Murty Pharmaceuticals, Inc - March 28, 2025

Source: https://www.globalkeysolutions.net/records/483/murty-pharmaceuticals-inc/17913da3-13d5-4315-a8de-444ab84c9681

> FDA 483 for Murty Pharmaceuticals, Inc on March 28, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Murty Pharmaceuticals, Inc
- Inspection Date: 2025-03-28
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Murty Pharmaceuticals, Inc. in Lexington, KY, identified two significant observations. The firm's laboratory controls were found deficient regarding sampling methods for microbial testing and the identification of microorganisms in their water system. Additionally, equipment logs lacked essential details such as time, product, and lot numbers for processed batches, hindering proper documentation.

## Related Officers

- [Heather R. Campbell](https://www.globalkeysolutions.net/people/heather-r-campbell/aaf80125-4322-45fe-a0f6-30cea8f1dbd2)
- [investigator](https://www.globalkeysolutions.net/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)

Company: https://www.globalkeysolutions.net/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22